Dr. Tom Patterson, chief of the Division of Infectious Diseases in the Long School of Medicine, was interviewed about a new study UT Health San Antonio and University Hospital are interested in joining. It is an “antibody cocktail” treatment. The remdesivir antiviral study he is leading also is mentioned.

Read the full story.

The post News 4: Local doctors hope to hold clinical trial for COVID ‘antibody cocktail’ treatment appeared first on UT Health San Antonio.